Joint Formulary & PAD

Formulary Search

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Search

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A-Z of Drugs

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search Results : Sickle-cell disease (Hydroxycarbamide - Sickle-cell disease)

Records returned : 3 (on 29 May 2025 at 13:27:21).

Show Icon and Status Keys

Drug
Indication
Status
Restrictions/Comments
Formulary Status
Links
Indication :
Status :
Blue
Formulations :
  • Capsules
Restrictions / Comments:

Important

Off-label use in Sickle Cell. Initiation and stabilisation (3 months) by the specialist team before any request for primary care prescribing.

 
Links :
SPC
Un
Indication :
Status :
Red
Formulations :
  • Oral solution
Restrictions / Comments:

Important

Sickle Cell in paediatrics - on advice from tertiary centre.

 
Links :
SPC
Un
Indication :
Status :
Non Formulary
Formulations :
  • Tablets
Restrictions / Comments:

Important

Tablets are considerably more expensive than capsules which have been agreed for off-label use in Sickle Cell.

 
Links :
SPC
NFD1